<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01812473</url>
  </required_header>
  <id_info>
    <org_study_id>ML8949</org_study_id>
    <secondary_id>2013-000559-42</secondary_id>
    <nct_id>NCT01812473</nct_id>
  </id_info>
  <brief_title>Plasma Protein Binding Characteristics of Voriconazole</brief_title>
  <official_title>Impact of Hypoalbuminemia on Voriconazole Pharmacokinetics in Critically Ill Adult Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the influence of hypoalbuminemia on the protein
      binding characteristics of the antifungal drug voriconazole in ICU patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in Overall Protein Binding in the Presence of Different Plasma Albumin Concentrations.</measure>
    <time_frame>At steady state plasma concentration of voriconazole (after day 4 of therapy)</time_frame>
    <description>At steady state plasma concentrations of voriconazole, a plasma sample is taken to determine the overall protein binding of voriconazole. Equilibrium dialysis is used, followed by liquid chromatography-mass spectrometry.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">35</enrollment>
  <condition>Focus of the Study:Protein Binding Characteristics of Voriconazole.</condition>
  <arm_group>
    <arm_group_label>Patients admitted to the Intensive Care Unit</arm_group_label>
    <description>All patients admitted to the Intensive Care Unit, treated with voriconazole are eligible for the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>During the treatment of voriconazole, at steady plasma concentrations of voriconazole, one plasma sample and one serum sample are taken.</description>
    <arm_group_label>Patients admitted to the Intensive Care Unit</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and serum samples are obtained to determine the albumin and alpha-1-acid-glycoprotein
      level.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to the intensive care unit
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  treated with voriconazole

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim Vanstraelen, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2013</study_first_submitted>
  <study_first_submitted_qc>March 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2013</study_first_posted>
  <results_first_submitted>January 13, 2015</results_first_submitted>
  <results_first_submitted_qc>January 30, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 18, 2015</results_first_posted>
  <last_update_submitted>March 3, 2015</last_update_submitted>
  <last_update_submitted_qc>March 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>protein binding</keyword>
  <keyword>voriconazole</keyword>
  <keyword>pediatrics</keyword>
  <keyword>hematology</keyword>
  <keyword>intensive care</keyword>
  <keyword>albumin</keyword>
  <keyword>alpha-1-acid-glycoprotein</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Voriconazole</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Patients Admitted to the ICU Not Treated With Voriconazole</title>
          <description>Patients admitted to the intensive Care Unit, with varying levels of plasma albumin concentrations during admission.
Plasma from this patients will be spiked in vitro with different voriconazole concentrations to investigate the influence of low albumine concentrations in plasma on voriconazole protein binding characteristics.</description>
        </group>
        <group group_id="P2">
          <title>Patients Admitted to the ICU Treated With Voriconazole</title>
          <description>Patients admitted to the Intensive Care Unit, treated with voriconazole are included in this study. Voriconazole protein binding will be determined and the correlation with albumin plasma concentrations will be evaluated.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Patients Admitted Tot the ICU Not Treated With Voriconazole</title>
          <description>Patients admitted to the intensive Care Unit, with varying levels of plasma albumin concentrations during admission.
Plasma from this patients will be spiked in vitro with different voriconazole concentrations to investigate the influence of low albumine concentrations in plasma on voriconazole protein binding characteristics.</description>
        </group>
        <group group_id="B2">
          <title>Patients Admitted to the ICU Treated With Voriconazole</title>
          <description>Patients admitted to the Intensive Care Unit, treated with voriconazole are included in this study. Voriconazole protein binding will be determined and the correlation with albumin plasma concentrations will be evaluated.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="35"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" lower_limit="60" upper_limit="74"/>
                    <measurement group_id="B2" value="62" lower_limit="57.5" upper_limit="71.5"/>
                    <measurement group_id="B3" value="65" lower_limit="58" upper_limit="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body weight</title>
          <units>kilogram</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71" lower_limit="60.3" upper_limit="80"/>
                    <measurement group_id="B2" value="68" lower_limit="61" upper_limit="82.5"/>
                    <measurement group_id="B3" value="68" lower_limit="62" upper_limit="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Acute Physiology and Chronic Health Evaluation (Apache) score</title>
          <description>Calculated as the sum of all parameters described below. Every parameter is scored a value of 0 to +4, 0 being normal +4 being very high or low abnormal. The total apache score ranges from 0 to 71, with higher values being associated with more severe disease and higher mortality risk.
Parameters included:Pa02 (arterial blood oxygen tension), rectal body temperature, Mean arterial pressure, arterial pH, heart rate, respiratory rate, serum sodium, serum potassium, serum creatinine, hematocrit, white blood cell count, glasgow coma scale.</description>
          <units>units of the Apache Scoring system</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.5" spread="10"/>
                    <measurement group_id="B2" value="26.8" spread="6.9"/>
                    <measurement group_id="B3" value="25.3" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Albumin plasma concentration</title>
          <units>gram/liter</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.7" lower_limit="14.4" upper_limit="33.7"/>
                    <measurement group_id="B2" value="31.1" lower_limit="13.8" upper_limit="38.7"/>
                    <measurement group_id="B3" value="26.7" lower_limit="13.8" upper_limit="38.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>alfa-1-acid glycoprotein plasma concentration</title>
          <units>gram/liter</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.4" lower_limit="0" upper_limit="2.4"/>
                    <measurement group_id="B2" value="1.8" lower_limit="1.1" upper_limit="3"/>
                    <measurement group_id="B3" value="1.5" lower_limit="0" upper_limit="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total plasma protein concentration</title>
          <units>gram/liter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.4" spread="12.4"/>
                    <measurement group_id="B2" value="56.6" spread="7.3"/>
                    <measurement group_id="B3" value="54.2" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total plasma bilirubin concentration</title>
          <units>milligram/liter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.75" lower_limit="0.42" upper_limit="1.93"/>
                    <measurement group_id="B2" value="0.41" lower_limit="0.28" upper_limit="1.69"/>
                    <measurement group_id="B3" value="0.67" lower_limit="0.42" upper_limit="1.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Blood Urea Nitrogen</title>
          <units>milligram/deciliter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.5" lower_limit="37" upper_limit="146"/>
                    <measurement group_id="B2" value="70" lower_limit="44.8" upper_limit="112.5"/>
                    <measurement group_id="B3" value="57.5" lower_limit="37" upper_limit="132.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Creatinin plasma concentration</title>
          <units>milligram/deciliter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.14" lower_limit="0.67" upper_limit="1.99"/>
                    <measurement group_id="B2" value="0.95" lower_limit="0.52" upper_limit="1.57"/>
                    <measurement group_id="B3" value="1.13" lower_limit="0.67" upper_limit="1.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>estimated Glomerular Filtration Rate (CKD-EPI equation)</title>
          <units>ml/min * 1.73m²</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" lower_limit="40" upper_limit="93"/>
                    <measurement group_id="B2" value="84" lower_limit="37.5" upper_limit="108.3"/>
                    <measurement group_id="B3" value="74" lower_limit="40" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>C reactive protein plasma concentration</title>
          <units>milligram/liter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72.1" lower_limit="48.2" upper_limit="89.6"/>
                    <measurement group_id="B2" value="47.2" lower_limit="21.6" upper_limit="116.9"/>
                    <measurement group_id="B3" value="71.5" lower_limit="30.8" upper_limit="92.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Voriconazole daily dose</title>
          <units>milligram/kilogram/day</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Plasma from ICU patients was spiked with 1.5, 2.9 and 9 milligram/liter of voriconazole.</measurement>
                    <measurement group_id="B2" value="8" lower_limit="7.5" upper_limit="8.3"/>
                    <measurement group_id="B3" value="NA">In study A: Plasma from ICU patients was spiked with 1.5, 2.9 and 9 milligram/liter of voriconazole.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Total voriconazole plasma concentration</title>
          <units>milligram/liter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">Plasma was spiked with 1.5, 2.9 and 9 milligram/liter voriconazole</measurement>
                    <measurement group_id="B2" value="2.4" lower_limit="1.5" upper_limit="4.5"/>
                    <measurement group_id="B3" value="2.9" lower_limit="1.5" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Unbound voriconazole plasma concentration</title>
          <units>milligram/liter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.86" lower_limit="0.45" upper_limit="2.66"/>
                    <measurement group_id="B2" value="0.71" lower_limit="0.51" upper_limit="1.46"/>
                    <measurement group_id="B3" value="0.85" lower_limit="0.46" upper_limit="2.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Bound voriconazole plasma concentration</title>
          <units>milligram / liter</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.63" lower_limit="0.85" upper_limit="5.35"/>
                    <measurement group_id="B2" value="1.52" lower_limit="1.07" upper_limit="2.57"/>
                    <measurement group_id="B3" value="1.62" lower_limit="0.87" upper_limit="5.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of coadministered drugs bound to proteins for more then 70%</title>
          <units>number of coadministered drugs</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.5" lower_limit="1" upper_limit="6"/>
                    <measurement group_id="B2" value="2.5" lower_limit="2" upper_limit="3"/>
                    <measurement group_id="B3" value="3" lower_limit="2" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Differences in Overall Protein Binding in the Presence of Different Plasma Albumin Concentrations.</title>
        <description>At steady state plasma concentrations of voriconazole, a plasma sample is taken to determine the overall protein binding of voriconazole. Equilibrium dialysis is used, followed by liquid chromatography-mass spectrometry.</description>
        <time_frame>At steady state plasma concentration of voriconazole (after day 4 of therapy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patients Admitted Tot the ICU Not Treated With Voriconazole</title>
            <description>Patients admitted to the intensive Care Unit, with varying levels of plasma albumin concentrations during admission.
Plasma from this patients will be spiked in vitro with different voriconazole concentrations to investigate the influence of low albumine concentrations in plasma on voriconazole protein binding characteristics.</description>
          </group>
          <group group_id="O2">
            <title>Patients Admitted to the ICU Treated With Voriconazole</title>
            <description>Patients admitted to the Intensive Care Unit, treated with voriconazole are included in this study. Voriconazole protein binding will be determined and the correlation with albumin plasma concentrations will be evaluated.</description>
          </group>
        </group_list>
        <measure>
          <title>Differences in Overall Protein Binding in the Presence of Different Plasma Albumin Concentrations.</title>
          <description>At steady state plasma concentrations of voriconazole, a plasma sample is taken to determine the overall protein binding of voriconazole. Equilibrium dialysis is used, followed by liquid chromatography-mass spectrometry.</description>
          <units>% of plasma protein binding</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="13"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Plasma samples</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.1" lower_limit="42.6" upper_limit="52.3"/>
                    <measurement group_id="O2" value="49.6" lower_limit="42.5" upper_limit="52.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Patients Admitted Tot the ICU Not Treated With Voriconazole</title>
          <description>Patients admitted to the intensive Care Unit, with varying levels of plasma albumin concentrations during admission.
Plasma from this patients will be spiked in vitro with different voriconazole concentrations to investigate the influence of low albumine concentrations in plasma on voriconazole protein binding characteristics.</description>
        </group>
        <group group_id="E2">
          <title>Patients Admitted to the ICU Treated With Voriconazole</title>
          <description>Patients admitted to the Intensive Care Unit, treated with voriconazole are included in this study. Voriconazole protein binding will be determined and the correlation with albumin plasma concentrations will be evaluated.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Relatively small data set.
Only adult ICU patients.
No data are available for plasma albumin concentrations above 40 g/liter.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Kim Vanstraelen, PharmD</name_or_title>
      <organization>Universitaire Ziekenhuizen Leuven</organization>
      <phone>0032 16 342339</phone>
      <email>kim_vanstraelen@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

